The 20 Best Malignant Peripheral Nerve Sheath Tumor Doctors in The United States

Dr. Christine Pratilas is a pediatric medical oncologist at the Sidney Kimmel Comprehensive Cancer Center and Associate Professor of Oncology, Pediatrics & Cellular and Molecular Medicine at the Johns Hopkins University School of Medicine. She joined the Hopkins pediatric sarcoma team in 2014. Dr. Pratilas received her undergraduate degree in Biology from Drew University in New Jersey and her medical degree from UMDNJ - Robert Wood Johnson Medical School (now Rutgers University), where she also completed her internship and residency from 1999 to 2002. From 2002 to 2005 she was a fellow in hematology and oncology in the Memorial Sloan Kettering Cancer Center (MSKCC) Department of Pediatrics, and in the Department of Pediatric Hematology and Oncology at New York Weill Cornell Medical Center. She was a postdoctoral research fellow in Dr. Neal Rosen’s Molecular Oncogenesis Laboratory at MSKCC. From 2006 to 2014 she was attending in Pediatric Oncology at MSKCC, specializing in developmental therapeutics & sarcoma. She has been the director of the pediatric sarcoma program at Hopkins since 2018. Dr. Pratilas focuses her research on cancer-associated pathways and signal transduction, which involves figuring out how a cell’s internal molecular pathways work, and how those pathways can be molecularly controlled. This knowledge is the basis for developing promising new molecularly targeted cancer therapies, which is the focus of Dr. Pratilas’s research. Among her important scientific contributions is advancing our understanding of how certain proteins that can be mutated in cancer, known as RAF kinases (specifically BRAF), affect a cancer cell’s behavior. The research in Dr. Pratilas' laboratory is focused on RAS signal transduction pathways, concentrating on pediatric sarcomas such as rhabdomyosarcoma and malignant peripheral nerve sheath tumors, in order to develop novel therapeutics for children with these tumors. Dr. Pratilas is rated as an Elite provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Malignant Peripheral Nerve Sheath Tumor, Neurofibromatosis Type 1 (NF1), Neurofibromatosis, Adult Soft Tissue Sarcoma, and Osteotomy. Dr. Pratilas is board certified in American Board Of Pediatrics.

Gary Schwartz is a Hematologist Oncology provider practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 47 years. Dr. Schwartz is rated as an Elite provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Fibrosarcoma, Hepato-Pancreato-Biliary Surgery, and Liver Embolization. Dr. Schwartz is board certified in American Board Of Internal Medicine, 1986.

Angela Hirbe is an Oncologist practicing medicine in Saint Louis, Missouri. She has been practicing medicine for over 17 years. Dr. Hirbe is rated as an Elite provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Malignant Peripheral Nerve Sheath Tumor, Fibrosarcoma, Neurofibromatosis Type 1 (NF1), and Adult Soft Tissue Sarcoma.

Brigitte Widemann is a Hematologist and an Oncologist practicing medicine in Bethesda, Maryland. Dr. Widemann is rated as an Elite provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Neurofibromatosis Type 1 (NF1), Neurofibromatosis, Malignant Peripheral Nerve Sheath Tumor, Adult Soft Tissue Sarcoma, and Thyroidectomy.

Steven Carroll is a primary care provider, practicing in Internal Medicine in Augusta, Georgia. Dr. Carroll is rated as an Elite provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Malignant Peripheral Nerve Sheath Tumor, Fibrosarcoma, Neurofibromatosis Type 1 (NF1), and Neurofibromatosis.

Ping Chi is an Oncologist practicing medicine in New York, New York. Dr. Chi is rated as an Elite provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Gastrointestinal Stromal Tumor, Malignant Peripheral Nerve Sheath Tumor, Fibrosarcoma, Undifferentiated Pleomorphic Sarcoma, and Endoscopy. Dr. Chi is currently accepting new patients.

William Tap is an Oncologist practicing medicine in New York, New York. Dr. Tap is rated as an Elite provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Gastrointestinal Stromal Tumor, Angiosarcoma, Tissue Biopsy, and Liver Embolization. Dr. Tap is currently accepting new patients.

Robert Spinner is a Neurosurgery provider practicing medicine in Rochester, Minnesota. Dr. Spinner is rated as an Elite provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Accessory Deep Peroneal Nerve, Mononeuritis Multiplex, Erb's Palsy, Nerve Decompression, and Tissue Biopsy.

Joseph Pressey is a Hematologist and an Oncologist practicing medicine in Cincinnati, Ohio. Dr. Pressey is rated as an Elite provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Malignant Peripheral Nerve Sheath Tumor, Ewing Sarcoma, Adult Soft Tissue Sarcoma, and Osteosarcoma.

. Dr. Shipstone is rated as an Experienced provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. He is also highly rated in 54 other conditions, according to our data. His clinical expertise encompasses Adult Immune Thrombocytopenia, Colorectal Cancer, Hemangioma Thrombocytopenia Syndrome, and Thrombocytopenia. Dr. Shipstone is board certified in American Board Of Internal Medicine.

Bradley Beeler, MD, provides comprehensive care for patients with all stages of oncological malignancies and the full spectrum of hematological conditions. His expertise includes the treatment and management of benign and malignant hematologic disorders, bone marrow failure syndromes, transfusion support and advanced cellular therapies. He has specialized training in hematopoietic stem cell transplantation and cellular therapy, offering advanced options for eligible patients. A former Lieutenant Colonel in the United States Air Force, Dr. Beeler served more than 10 years on active duty, caring for service members, retirees and their families. “Helping patients reach milestones they feared they wouldn’t see, like attending a graduation or holding a grandchild, is what makes this work so meaningful,” he says. As an ETSU Health clinician, Dr. Beeler also serves as a faculty member at ETSU’s Quillen College of Medicine. Originally from Knoxville, he is grateful to return to the Appalachian Highlands and enjoys spending time outdoors with his wife and children. Dr. Beeler is rated as an Experienced provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. His clinical expertise encompasses Malignant Peripheral Nerve Sheath Tumor, Fibrosarcoma, Hemolytic Transfusion Reaction, and Parathyroid Cancer. Dr. Beeler is board certified in American Board Of Internal Medicine.

Dr. Ahrendt is a board certified medical oncologist originally from Boston, Massachusetts. She earned a bachelor's degree in biology from Washington University in St. Louis, Missouri, followed by a medical degree from the Drexel University Hahnemann School of Medicine in Philadelphia, Pennsylvania. Dr. Ahrendt completed an internship, residency and a combined hematology/oncology fellowship at Tufts New England Medical Center in Boston. Dr. Ahrendt pursued a career in medicine because of her desire to help those in need and being able to make an impact on people’s ability to get through disease and difficult situations.“The key to successful treatment of cancer is having a team-based approach. The relationship between the patient, family members, doctors, nurses and support services is so important.”  Dr. Ahrendt’s clinical interests include breast cancer, colorectal cancer, lung cancer, chronic myeloid leukemia (CML), and chronic lymphocytic leukemia (CLL). Dr. Ahrendt is an investigator involved in clinical research trials in the areas of medical oncology and hematology. Her research includes oncology and hematology. She has been practicing oncology in Denver since 2004 and is currently accepting new patients. When she is not at work, Dr. Ahrendt enjoys skiing, camping, hiking and fishing with her husband and son. Dr. Ahrendt is rated as an Experienced provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Ahrendt is board certified in American Board Of Internal Medicine. Dr. Ahrendt is currently accepting new patients.

Dr. Kyle Work joined the Cancer Centers of Colorado at St. Mary?s Medical Center oncology team in 2018. He is a hematologist-oncologist. Dr. Work treats all types of cancers with a special interest in head and neck cancer, lung cancer and genitourinary cancers.Dr. Work is originally from Tulsa, Oklahoma where he graduated from the University of Tulsa with a degree in biology, and earned his medical degree at Oklahoma State University. He then moved to Kansas City where he completed his internal medicine residency and hematology / oncology fellowship at the University of Kansas Health System. During his hematology and oncology fellowship, he served as chief fellow for two years.Dr. Work is an investigator involved in clinical research trials in the area of hematology and medical oncology. His clinical research focus includes head and neck cancers, brain and lung cancers. When he is not working, he enjoys mountain biking, camping, and hiking with his wife and golden retrievers. Dr. Work is rated as an Experienced provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer. Dr. Work is board certified in American Board Of Internal Medicine. Dr. Work is currently accepting new patients.

Dr. Kathryn Lemberg is an Assistant Professor of Oncology and Pediatrics at the Sidney Kimmel Comprehensive Cancer Center. Her research, conducted with Johns Hopkins Drug Discovery, focuses on tumor metabolism and the development of new metabolic inhibitors to treat cancer. She has investigated novel glutamine antagonists in preclinical models of RAS-driven solid tumors. She is also interested in the effects of tumor metabolism on patient growth and development. Dr. Lemberg completed pediatrics residency training at Johns Hopkins and pediatric hematology-oncology fellowship training in the joint Johns Hopkins/National Cancer Institute program. She received her M.D. and Ph.D. degrees from the Medical Scientist Training Program at Columbia University in New York, where her graduate research focused on ferroptosis, a novel oxidative cell death in cancer models. Dr. Lemberg sees pediatric and young adult sarcoma patients as part of the sarcoma team and has additional clinical focus on neurofibromatosis type I related solid tumors. Dr. Lemberg is rated as a Distinguished provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Malignant Peripheral Nerve Sheath Tumor, Neurofibromatosis Type 1 (NF1), Neurofibromatosis, and Adult Soft Tissue Sarcoma. Dr. Lemberg is board certified in American Board Of Pediatrics.

Gulam Manji, M.D., Ph.D. is an Associate Professor of Medicine at Columbia University Medical Center. Dr. Manji received his M.D. degree from Ross University School of Medicine in 2009 and completed his residency in internal medicine at Albany Medical College. He then completed his fellowship in Hematology/Oncology at NewYork-Presbyterian/Columbia, where his clinical focus was on the treatment of gastrointestinal malignancies, melanoma, and sarcoma under the mentorship of Dr. Gary Schwartz, Chief of Hematology and Oncology.Dr. Manji conducts translational research with the overall goal to developing new treatments for cancer. His focus is in gastrointestinal malignancies, particularly pancreas adenocarcinoma, on which he is conducting preclinical combination immunotherapy studies on genetically engineered mice with pancreas cancer in the Olive laboratory at the Herbert Irving Comprehensive Cancer Center. The combination immunotherapy preclinical proposal received the Young Investigator Award from the American Society of Clinical Oncology-2015. The goal of these preclinical studies is to bring promising new therapies to the clinic in an early phase clinical trials Dr. Manji's research career in identifying new genes and their implication in disease has led to numerous key publications and an issued patent.Dr. Manji cares for patients with gastrointestinal malignancies, with a particular focus on pancreatic and liver cancers, and sarcomas. He is the principal investigator of an investigator-initiated multicenter clinical trial that he wrote with Dr. Gary Schwartz in sarcoma and malignant peripheral nerve sheath tumors and is responsible for clinical trials conducted in liver, bile duct, gallbladder, and pancreas cancers at Columbia University Medical Center. Dr. Manji is rated as a Distinguished provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Malignant Peripheral Nerve Sheath Tumor, and Familial Pancreatic Cancer. Dr. Manji is board certified in Internal Medicine and Medical Oncology. Dr. Manji is currently accepting new patients.

Matthew Steensma is a Pediatrics specialist and a Surgical Oncologist practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 24 years. Dr. Steensma is rated as a Distinguished provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Fibrosarcoma, Malignant Peripheral Nerve Sheath Tumor, Neurofibromatosis, Adult Soft Tissue Sarcoma, and Hip Replacement. Dr. Steensma is board certified in American Board Of Orthopaedic Surgery. Dr. Steensma is currently accepting new patients.

Dr. Meyer will serve as the lead medical oncologist for adult sarcoma patients, and will focus on building the Adult Sarcoma and Connective Tissue Oncology Program. In collaboration with pediatric oncologist David Loeb, M.D., Ph.D., and orthopaedic surgeon Kristy Weber, M.D., Meyer will bring novel therapies to the clinic for sarcoma patients. Meyer received his bachelors and masters degrees in cell and molecular biology from Stanford University. From there, he joined the Medical Scientist Training Program at Baylor College of Medicine and earned his medical degree followed by a doctorate in immunology. Meyer completed his residency at the University of Maryland and served as chief resident in medicine from 2004-2005. Afterward, he joined our fellowship program in medical oncology and has been working in the laboratory of Jonathan Powell, M.D., Ph.D., on projects relating to the characterization of molecular regulatory pathways involved in T-cell activation and energy. As a third-year fellow, Meyer served as the chief fellow for our Training Programs in Hematology and Medical Oncology and he received a Young Investigator Award from the American Society of Clinical Oncology in 2010. Dr. Meyer is rated as a Distinguished provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Mesenchymoma, Undifferentiated Pleomorphic Sarcoma, Ganglioneuroblastoma, and Bone Tumor. Dr. Meyer is board certified in American Board Of Internal Medicine.

Jon Strasser is a Radiation Oncologist practicing medicine in Newark, Delaware. He has been practicing medicine for over 31 years. Dr. Strasser is rated as a Distinguished provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Malignant Peripheral Nerve Sheath Tumor, Pleuropulmonary Blastoma, and Intraductal Papilloma.

Dr. Ready is a member of the Department of Orthopaedic Surgery and is Chief of the Orthopaedic Oncology Service. In this role, Dr. Ready treats cancer patients with bone and soft tissue sarcoma, as well as patients with metastatic bone disease. He received subspecialty training in this field at Massachusetts General Hospital and Children’s Hospital Boston. He is an intricate member of a multidisciplinary treatment team that includes Medical Oncologists, Radiation Oncologists, Pathologists, Radiologists and other Surgical Subspecialists.  Patients may be seen at the Brigham and Women’s Hospital or at the Dana-Farber Cancer Institute. In addition to Orthopaedic Oncology, Dr. Ready has specialty training in reconstructive arthroplasty surgery of the hip and knee. He performs direct anterior approach total hip replacement, total knee replacement (including Mako robotic knee replacement) and complex cases of revision total hip and total knee arthroplasty.  He is also part of a team that performs Day Surgery total joint replacement at Brigham and Women's Hospital and Brigham and Women's Faulkner Hospital. Dr. Ready is rated as a Distinguished provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Bone Tumor, Ewing Sarcoma, Osteoarthritis, Hip Replacement, and Knee Replacement. Dr. Ready is board certified in Orthopaedic Surgery.

Dr. Allan Belzberg is a neurosurgeon specializing in surgery of the peripheral nervous system. As Director of Peripheral Nerve Surgery at Johns Hopkins in Baltimore, he treats tumors including schwannoma, neurofibroma and nerve sheath tumor. Dr. Belzberg performs surgical repair of nerve damage caused by trauma as well as neurosurgery on carpal tunnel, peroneal nerve and other peripheral nerve conditions. Dr. Belzberg also directs the Brachial Plexus and Peripheral Nerve Clinic at the Kennedy Krieger Institute and co-directs the Neurosurgery Pain Research Institute at Johns Hopkins Hospital. Dr. Belzberg currently sees patients at the Johns Hopkins Outpatient Center located in Baltimore on Wednesdays and the Green Spring Station location on Fridays. Dr. Belzberg is rated as a Distinguished provider by MediFind in the treatment of Malignant Peripheral Nerve Sheath Tumor. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Schwannomatosis, Neurofibromatosis, Thoracic Outlet Syndrome, Rhizotomy, and Laminectomy. Dr. Belzberg is board certified in American Board Of Neurological Surgery.